KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Non-Current Assets (2019 - 2025)

Hims & Hers Health's Non-Current Assets history spans 6 years, with the latest figure at $1.4 billion for Q3 2025.

  • For Q3 2025, Non-Current Assets rose 403.12% year-over-year to $1.4 billion; the TTM value through Sep 2025 reached $2.7 billion, up 232.65%, while the annual FY2024 figure was $311.7 million, N/A changed from the prior year.
  • Non-Current Assets for Q3 2025 was $1.4 billion at Hims & Hers Health, up from $522.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.4 billion in Q3 2025 and bottomed at $5.7 million in Q1 2021.
  • The 4-year median for Non-Current Assets is $186.4 million (2024), against an average of $302.7 million.
  • The largest YoY upside for Non-Current Assets was 2584.48% in 2021 against a maximum downside of 97.21% in 2021.
  • A 4-year view of Non-Current Assets shows it stood at $150.7 million in 2021, then fell by 0.62% to $149.7 million in 2022, then surged by 108.16% to $311.7 million in 2024, then surged by 345.3% to $1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Non-Current Assets are $1.4 billion (Q3 2025), $522.0 million (Q2 2025), and $444.7 million (Q1 2025).